Schoen Frederick J, Gotlieb Avrum I
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115; Pathology and Health Sciences and Technology (HST), Harvard Medical School, 75 Francis Street, Boston, MA 02115.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Laboratory Medicine Program, University Health Network, Medical Sciences Building, 1 King's College Circle, Rm. 6275A, Toronto, Ontario M5S 1A8, Canada.
Cardiovasc Pathol. 2016 Jul-Aug;25(4):341-352. doi: 10.1016/j.carpath.2016.05.002. Epub 2016 May 10.
The past several decades have witnessed major advances in the understanding of the structure, function, and biology of native valves and the pathobiology and clinical management of valvular heart disease. These improvements have enabled earlier and more precise diagnosis, assessment of the proper timing of surgical and interventional procedures, improved prosthetic and biologic valve replacements and repairs, recognition of postoperative complications and their management, and the introduction of minimally invasive approaches that have enabled definitive and durable treatment for patients who were previously considered inoperable. This review summarizes the current state of our understanding of the mechanisms of heart valve health and disease arrived at through innovative research on the cell and molecular biology of valves, clinical and pathological features of the most frequent intrinsic structural diseases that affect the valves, and the status and pathological considerations in the technological advances in valvular surgery and interventions. The contributions of many cardiovascular pathologists and other scientists, engineers, and clinicians are emphasized, and potentially fruitful areas for research are highlighted.
在过去几十年里,人们对天然瓣膜的结构、功能和生物学,以及心脏瓣膜病的病理生物学和临床管理的认识取得了重大进展。这些进步使得能够更早、更精确地进行诊断,评估手术和介入治疗的恰当时机,改进人工瓣膜和生物瓣膜的置换与修复,识别术后并发症并进行处理,还引入了微创方法,从而能够为以前被认为无法手术的患者提供确切而持久的治疗。本综述总结了我们目前对心脏瓣膜健康和疾病机制的认识,这些认识是通过对瓣膜细胞和分子生物学的创新性研究、影响瓣膜的最常见内在结构疾病的临床和病理特征,以及瓣膜手术和介入技术进步的现状及病理考量而得出的。文中强调了许多心血管病理学家以及其他科学家、工程师和临床医生所做出的贡献,并突出了潜在的富有成果的研究领域。
Cardiovasc Eng Technol. 2018-6
Annu Rev Pathol. 2011-9-19
Arch Mal Coeur Vaiss. 2007-1
Cardiovasc Pathol. 2005
Cardiovasc Pathol. 2002
G Ital Cardiol (Rome). 2008-3
J Tehran Heart Cent. 2023-4
J Cardiovasc Dev Dis. 2020-12-16
Biotech Histochem. 2019-2
J Mech Behav Biomed Mater. 2018-7-18